OLEG NODELMAN

CIK 1454385 · last filed 2026-01-12

OLEG NODELMAN is a corporate insider who has filed 18 SEC Form 4 insider transactions across 5 companies since 2013. The most recent filing, for AKTS, was dated Jan 12, 2026. Across all open-market trades the lifetime net is +$177.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $957.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$957.73M

Companies

5

Total Filings

18

Lifetime Open-Market Net

$177.46M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AKTS Director 347,305 $21.10 $7.33M $80.00M 1 2026-01-12
ZYME Director 22,970,388 $23.00 $528.32M $52.14M 9 2025-06-27
Nuvation Bio Inc. (NUVB.WS) Delisted Director 12,504,675 $0.01 $63.8K $40.15M 2 2023-09-22
ANAB Director 7,521,024 $56.12 $422.08M $0 1 2022-05-09
Kindred Biosciences, Inc. (KIN) Delisted Director 540,936 $9.25 $5.00M $5.16M 5 2014-09-30

Recent Filings

18 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-01-12 AKTS Mixed +9,648,938 $80.00M EDGAR
2025-06-27 ZYME Mixed +10,172,878 -$25 EDGAR
2025-05-19 ZYME Buy (P) +110,842 $1.27M EDGAR
2025-04-18 ZYME Buy (P) +257,426 $2.91M EDGAR
2025-04-07 ZYME Buy (P) +634,416 $7.25M EDGAR
2025-04-02 ZYME Buy (P) +254,830 $2.99M EDGAR
2025-03-27 ZYME Buy (P) +194,698 $2.45M EDGAR
2025-03-24 ZYME Buy (P) +254,396 $3.29M EDGAR
2025-03-19 ZYME Buy (P) +456,926 $5.73M EDGAR
2025-03-13 ZYME Buy (P) +2,163,960 $26.24M EDGAR
Showing 110 of 18
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.